the FHH strain increases the susceptibility of the kidney to develop damage after UNx combined with Background. Fawn-hooded hypertensive (FHH ) rats carry several genes which determine the susceptibility systemic hypertension. to develop renal damage, while renal damage resistant Keywords: fawn-hooded rats; genetic susceptibility; August×Copenhagen Irish (ACI ) rats do not. Kidneys glomerulosclerosis; hypertension; renal damage from heterozygous ( FHH×ACI ) F 1 rats, appear to be largely, but not completely, protected after blood pressure elevation with Nv-nitro--arginine methyl ester (L-NAME ). We examined the role of an increased Introduction haemodynamic burden on the development of renal damage combining unilateral nephrectomy ( UNx)-and
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The fawn-hooded hypertensive ( FHH ) rat is a unique L-NAME-induced hypertension in F 1 and ACI rats. model of hypertension-associated renal damage [1] . Additionally, we investigated whether a general toxic Males develop mild systolic hypertension, progressive effect of L-NAME, independent from a blood pressure albuminuria ( UaV ), and focal glomerulosclerosis elevation, caused renal damage in F 1 rats in animals ( FGS) at a relatively young age. Previous studies in simultaneously treated with L-NAME and the ACE FHH rats showed the presence of hyperfiltration and inhibitor lisinopril. glomerular hypertension preceding the development of Methods. Surgery was performed and L-NAME treatfunctional and structural renal damage [2] . In the ment (50 or 150 mg/l ) was started at the age of 15 FHH rat, renal damage is greatly enhanced by unilatweeks. Systolic blood pressure (SBP) and urinary eral nephrectomy ( UNx) [3] , a procedure that will albumin excretion ( UaV ) were measured at 6 and 12 further increase the haemodynamic burden to the weeks post-UNx, followed by autopsy to determine glomeruli. A linear relationship was found between the incidence of focal glomerulosclerosis (FGS ). Using systolic blood pressure and intraglomerular pressure lisinopril (LIS) and L-NAME, another group of rats in three groups of UNx rats with different SBP levels was evaluated at 12, 18, and 24 weeks after start of [4] . A relatively high efferent arteriolar resistance in treatment.
combination with a decreased ability to increase Results. At similar L-NAME intake, F, rats developed afferent tone was also found in the FHH rat, suggesting more severe hypertension and more UaV than ACI an impairment in the control of renal vascular resistance. rats. The increase in UaV per mmHg increase in SBP Genetic factors influencing the development was fivefold higher in F 1 compared with ACI rats. In and progression of renal damage are apparent in F 1 rats, the increase in UaV per percentage incidence FHH rats. Using a back-cross of (FHH× increase in FGS was three times higher. In LIS treated August×Copenhagen Irish (ACI )) F 1 ×FHH rats, we F 1 rats, no significant UaV or FGS was measured at mapped two quantitative trait loci (QTLs) on chromolow blood pressure levels, indicating that renal damage some 1, influencing proteinuria and structural renal in hypertensive F 1 rats is not a direct effect of damage [5] . These genes were denoted Rf-1 and Rf-2. L-NAME, but the result of the high blood pressure or Rf-1 appeared at least partly independent from blood another action of the renin-angiotensin system. pressure. In a subsequent study, the development Conclusion. We conclude that heterozygosity for the of renal damage after UNx was assessed in a genes influencing the development of renal damage in ( FHH×ACI ) F 2 progeny [6 ] . Linkage analysis in this F 2 cross not only confirmed the importance of Rf-1 Correspondence and offprint requests to: Richard P. E. van Dokkum and Rf-2, but also revealed the presence of three PhD, Erasmus University Medical School, Department of Pediatric additional QTLs (Rf-3, Rf-4, and Rf-5) influencing the renal damage after UNx is influenced by at least five Design study 1 susceptibility genes.
Chronic nitric-oxide inhibition was started after the rats had Previously we have studied the effects of hypertenrecovered from surgery for 3-4 days using L-NAME, (Sigma sion induced by chronic nitric oxide (NO) inhibition Chemical Co., St Louis, MO) dissolved in the drinking water with Nv-nitro--arginine methyl ester (L-NAME) on at a concentration of 50 or 150 mg/l to obtain various blood the development of renal damage in F 1 (FHH×ACI ) pressure elevations, and was based on previous experiments rats and in both parental strains with two kidneys. It [7] . This dose was slightly lower compared with previous was shown that despite similar levels of systolic blood studies in two-kidney rats, because some F 1 animals died in pressure (SBP), severe UaV, and FGS were present in that study as a result of L-NAME-induced complications. FHH rats, while ACI rats developed hardly any renal Control animals were provided with normal drinking fluid.
Animals from each strain were divided into three groups, damage [7] . The most important finding in the F 1 rats and were age-and body weight-matched. The F 1 groups (n= was that, although these hybrids developed less renal 29) consisted of nine control rats, 10 rats treated with 50 mg damage compared with FHH rats, being heterozygous L-NAME, and 10 rats treated with 150 mg L-NAME. The for the susceptibility genes did not completely protect ACI groups (n=26) consisted of 10 control rats, six rats the kidney from developing UaV and FGS. Compared treated with 50 mg L-NAME, and 10 rats treated with with ACI rats, the severity of UaV and FGS increased, 150 mg L-NAME. Actual L-NAME intake was calculated especially at SBP levels above 180 mmHg.
in mg/kg from the metabolic data at 6 and 12 weeks after
The purpose of the present study was to assess the UNx. genetic susceptibility to develop renal damage after UNx in combination with L-NAME-induced hyperten-Design study 2 sion. The changes in UaV and SBP at 6 and 12 weeks after UNx and L-NAME-induced hypertension were Blood pressure was maintained at low levels by chronic angiotensin-converting enzyme inhibition (ACE-i), using lisi- after surgery, rats were sacrificed, creatinine clearance
The Netherlands), that was administered through the was measured, and morphological studies were perdrinking water at a concentration of 50 mg/l. This dose was formed in kidney tissue to determine structural renal used because it had previously proven to provide adequate damage. FHH rats were not included in these studies blood pressure reduction in FHH rats [8] . As in study 1, because of their high susceptibility and mortality in hypertension was induced using L-NAME. The F 1 rats were response to chronic L-NAME treatment [7] , especially divided into three age-and body weight-matched groups, in combination with UNx [4] .
and were measured 12, 18, and 24 weeks after UNx. The A second study was carried out under a similar end-point of study 1 was taken as a starting-point for this study to obtain a longer follow-up period in F 1 rats with protocol to exclude the possibility of renal damage different blood pressure levels.
being a direct toxic effect of L-NAME. In this study,
The control and L-NAME groups consisted of eight rats. F 1 rats were treated with L-NAME and the angio-
The third group (NAME+LIS) consisted of nine rats that tensin-converting enzyme inhibitor (ACEI ) lisinopril, were simultaneously treated with L-NAME and LIS. to keep SBP at a low concentration. The SBP and Treatment was started after the rats had recovered from UaV levels were measured 12, 18, and 24 weeks after surgery for 3-4 days and continued until the final measureUNx in control and treated groups.
ment at 24 weeks after UNx. Also in this study, actual L-NAME intake was calculated in mg/kg from the metabolic data at 12, 18, and 24 weeks after UNx.
SBP and metabolic measurements

Subjects and methods
SBP was measured as previously described [7] . The week Animals before the measurement, animals were allowed to adapt to the equipment and the procedure to minimize stress-induced Fifty-five animals were used in study 1, and 25 animals were artefacts. Although SBP was measured every 3 weeks after used in study 2. All animals were 15 weeks of age at the time UNx, only the values obtained at the time of the metabolic the study was started. The FHH and ACI rats were all derived measurements will be presented. Urine excretion, food and from our own breeding nuclei, and the F 1 (FHH×ACI ) rats water intakes were determined. gravimetrically in two 24-h were specially bred for the study. The rats received acidified collections at 6 and 12 weeks after UNx in study 1 and 12, tap-water (pH 3.0) ad libitum and standard rat chow (Hope 18, and 24 weeks after UNx in study 2, as described Farms, Woerden, The Netherlands) containing 1% NaCl.
previously [7] . Rats were allowed to adapt to the metabolic cages over the weekend.
UNx Terminal analysis
The right kidney was removed using ethyl ether (Sigma Autopsy of the rats, processing of kidneys were performed Chemical Co., St Louis, MO) anaesthesia, administered as described previously [7] . The criteria for the assessment through an evaporation system connected to an airtight box. of the incidence of FGS were adhesion of the glomerulus to Rats were allowed to recover from surgery in a warmed cage Bowman's capsule, periodic acid-Schiff-positive material in the mesangial region, and folding of the glomerular basement for 1-2 h. membrane with entrapment of amorphous material. Final ACI-CON rats and averaged around 130 and creatinine clearance as a measure of glomerular filtration 110 mmHg respectively. Chronic L-NAME treatment rate (GFR) was calculated from the plasma creatinine con-induced dose-dependent differences in SBP that were centrations from blood obtained at autopsy and from the already statistically significant at the first time-point. urinary creatinine concentration obtained at the last meta-Treated F 1 rats developed significantly higher SBP bolic measurement shortly before autopsy. levels than treated ACI rats. These significant differences between F 1 and ACI remained present during Analytic procedures the entire follow-up. From the first time-point onwards, SBP concentrations increased, although not dramaticPlasma and urinary albumin concentration was measured ally, in both the ACI-50 and in ACI-150 groups with bromocresol green (Merck, Darmstadt, Germany), and respectively. The increase in SBP was also modest in creatinine with the Jaffé method without deproteinization the F 1 -50 group. In contrast, SBP increased more using the semi-automatic ELAN system (Merck-Eppendorf, steeply in the F 1 -150 group. The groups that developed Hamburg, Germany).
similar levels of SBP were the F 1 -CON and the ACI-50, and the F 1 -50 and the ACI-150 groups.
Statistics
The level of functional renal damage, as indicated by the level of UaV, rose in a dose-dependent fashion Data are presented as mean±SEM in the figures, text, and in all strains, and is also shown in weeks of 150 mg L-NAME treatment.
The relationships between SBP and UaV, and between the level of UaV at week 12 and the incidence of FGS was Structural renal damage and final GFR The level of assessed by linear regression analysis. All tests were per-structural damage, as indicated by FGS, is shown in formed using the Primer of Biostatistics (S. E. Glantz) Table 3 . Both strains showed a dose-dependent increase software package.
in FGS. The incidence of FGS in the F 1 -150 group was significantly higher compared with all other groups. The 50 mg-treated groups of both strains showed sim-
Results
ilar FGS incidence.
At autopsy, the calculated creatinine clearance, used Study 1 as an estimate for final GFR, was significantly higher in all groups of F 1 rats compared with ACI-CON and Blood pressure and albuminuria The actual L-NAME 50 mg-treated rats, as shown in Table 3 . GFR was sigintake was calculated from the fluid intake at the nificantly lower in the 150 mg-treated groups of both metabolic measurements and is given in Table 1 . No strains compared with the 50 mg-treated groups, but statistical significant differences between strains at the still significantly higher in the F 1 compared with the measured time-points were detected.
ACI rats. The values for SBP in both F 1 and ACI control (ACI-CON ) rats and after L-NAME treatments are
Renal damage in groups with similar SBP levels The summarized in Table 2 . SBP in control F 1 (F 1 -groups that develop similar levels of SBP appeared to CON ) rats was significantly higher compared with be the FI-CON and the ACI-50, and the F 1 -50 and the ACI-150 groups respectively. The SBP level in these treated ACI and F 1 rats were included in the regression in Table 1 , and showed no significant differences between the F 1 groups. analysis, which is shown in Figure 1A ,B respectively. Already at 6 weeks, the slope of the best-fit regression
Longitudinal values for the tail-cuff SBP and UaV at 12, 18, and 24 weeks after UNx are shown in line was significantly higher in F 1 compared with ACI rats, and averaged 0.17±0.01 (r=0.397, Figure 2A ,B respectively. Also in this study, SBP in L-NAME-treated rats was significantly higher than P=0.033) and 0.10±0.01 (r=0.709, P<0.01) mg/24 h per mmHg. At week 12 after UNx, the that of the control group. In contrast, SBP in the L-NAME+LIS rats was significantly lower compared increase in UaV per mmHg increase in SBP was five times more in F 1 than in ACI rats. Values averaged with the control rats. The SBP in the L-NAME group increased to around 200 mmHg at week 24 after UNx. 1.24±0.04 (r=0.807, P<0.001) and 0.25±0.01 (r= 0.70, P<0.001) mg/24 h per mmHg respectively, and The SBP levels in the control and L-NAME+LIS group remained stable around 135 and 100 mmHg, indicate that the amount of functional damage between week 6 and 12 was sevenfold in F 1 , and almost three-respectively. A similar picture emerged for the UaV levels, which fold in ACI.
Furthermore, a significant correlation between FGS increased steeply with time in the NAME treated group. UaV in the control group also progressively and UaV was present in both strains. The increase in UaV per percentage increase in FGS incidence increased, although much less than in the L-NAME treated group. The rats treated simultaneously with was three times higher (P<0.001) in F 1 compared with ACI rats and averaged 3.98±0.09 (r=0.844, L-NAME+LIS did not develop any significant UaV during the entire period, the average level being around P<0.001), and 1.31±0.05 (r=0.695, P<0.001) mg/24 h respectively. Furthermore, per percentage 2 mg/24 h. increase in FGS, F 1 rats showed an increase in LKW/100 g BW of 0.25±0.01 (r=0.643, P=0.01), Final GFR and structural renal damage Final creatinine whereas ACI rats did not show a significant correlation clearance as an indicator of final GFR were equal in between those parameters. the NAME and NAME+LIS groups and averaged 1.21±0.07 and 1.2±0.1 ml/min respectively. The clearStudy 2 ance in the control group was slightly, but not significantly, higher compared with the other groups and Blood pressure and albuminuria The actual L-NAME intakes of the F 1 rats used in this study are also given averaged 1.42±0.07 ml/min. Final GFR in the CON (CON, &, n=8 ), rats treated with 150 mg/l L-NAME (NAME, + n=8), and rats treated with 50 mg/l LIS and 150 mg/l L-NAME directly after UNx (NAME+LIS, ,, n=9). Values are given as mean±SE (error bars).
indicates that in this group an even stronger correlation was present between the SBP level and UaV compared with study 1. group was slightly, but not significantly, higher than in the NAME and NAME+LIS groups. The level of structural damage, indicated by the incidence of FGS Discussion was significantly higher in the NAME group compared with the other groups, and averaged 27.1±2.7%. The The primary finding of the first study was that in F 1 incidence of sclerosis was significantly higher in the and ACI rats, L-NAME in combination with UNx control compared with the NAME+LIS group and caused a dose-dependent increase in blood pressure averaged 16.3±2.9, and 4.8±0.8% respectively. Long-and renal damage. However, with the same L-NAME term concomitant ACEI treatment completely pre-dose, F 1 rats developed more severe hypertension and vented the development of FGS after UNx and more functional and structural renal damage L-NAME treatment. Furthermore, as evidenced by the per mmHg increase in SBP than did the treated ACI significantly lower incidence in the NAME+LIS rats. Additional regression analysis showed significant group, ACEI also reduced the incidence of FGS when linear relationships between functional and structural compared with the control group. Thus the lower SBP parameters 12 weeks post-UNx in both strains, being levels in NAME+LIS-treated F 1 rats appears to pre-three times more severe in F 1 than in ACI rats. The vent the development of both functional ( UaV ) and primary finding of the second study was that the structural ( FGS ) renal damage.
development of renal damage in F 1 rats appeared to depend on the L-NAME-induced hypertension and not on a direct toxic effect of L-NAME. With a similar Regression analysis study 2 Linear regression analysis using the SBP and UaV data obtained at 12, 18, and 24 L-NAME intake, prevention of the rise in blood pressure by LIS completely prevented the development of weeks after UNx showed significant relationships between these parameters (r=0.787, P<0.001; r= functional and structural renal damage.
By comparing the creatinine clearance in the present 0.828, P<0.001; r=0.825, P<0.001). Furthermore, a significant correlation between FGS and UaV was pre-study with those obtained in a previous study performed in F1 and ACI rats with two kidneys (2K ) sent at 24 weeks after UNx (r=0.805, P<0.001). This after similar L-NAME intake [7] , we were able to appears that adequate renal autoregulation is of major importance in protecting the glomerulus from the calculate the compensatory increases in GFR after UNx. It appears that the compensatory increase in F 1 transmission of systemic pressure into the capillary bed. We recently observed an impaired renal autoregurats was significantly higher compared with ACI rats. In control F 1 rats, the final GFR after UNx on average lation leading to glomerular hypertension in the FHH rat [19] . Moreover, isolated perfused interlobular arterincreased by 59% compared with 2K-F 1 rats. In control ACI rats, the level after UNx was only 17% higher ies of the FHH rat showed an impaired myogenic response, which contributes to the development of than in 2K-ACI rats. This data indicates that F 1 rats were less efficiently protected from an increase in GFR renal damage in this animal model [20] .
Regulation of renal vascular resistance, intrathan ACI and might indicate differences in renal haemodynamic regulatory mechanisms between the glomerular pressure, and glomerular filtration might be genetically determined and thereby predispose to strains. Our data support the view that, at low-dose L-NAME, the renal vasoconstriction caused by renal failure if P GC is excessively high. The recent findings that genes determining renal failure and blood L-NAME leads to an increase in filtration and an increase in FGS due to a larger haemodynamic burden pressure in the FHH rat are separate and distinct from each other could be a possible explanation for the compared with the control groups in ACI and F 1 rats. At high dose L-NAME, increasing constriction causes strain differences in the susceptibility to develop glomerular damage. Experiments in which rats of an F 2 a decrease in filtration and a further increase in FGS due to ischaemic factors. The presence of an increase cross between ACI and FHH rats were studied after UNx, not only confirmed the results of an earlier study in filtration solely due to the reduction of renal mass might also play an additional role in this process [9, 10] . in a back-cross of both strains, but also revealed the presence of three additional loci for renal failure [5, 6 ] . The male FHH rat, the parental strain of the F 1 rats used in the present study, develops mild systolic, but These findings underscore the complexity of the genetics to progressive renal failure and might point towards marked glomerular hypertension, and is extremely susceptible to develop renal damage [1] [2] [3] [4] [5] . Glomerular specific genetically regulated mechanisms related to changes induced by UNx. hypertension and the severity of renal damage in the FHH is further increased by UNx [3, 4] . The glomerular Alterations in the glomerular permeability of proteins, allowing the development of UpV, can occur capillary pressure (P GC ) level in UNx-FHH rats was found to be higher than those reported following UNx while GFR remains within normal limits in different renal diseases both in animals and humans [21] . The in MW or Wistar Kyoto ( WKY ) rats [11, 12] , strains that are less susceptible to the development of renal persistence of UpV in the presence of normal GFR can be considered an independent risk factor for the damage than the FHH rat. However, P GC in UNx-FHH is comparable to that reported for MW rats with development of renal failure, since no correlations were found between UpV and GFR in the rats used in the remnant kidneys [13] . In general, normotensive rat strains appear less susceptible than hypertensive first study after UNx and in the second study after L-NAME and ACEI treatment. The levels of final strains. We have previously studied the normotensive WAG, in which survival time after UNx is only slightly GFR in the present study showed that, compared with ACI rats, the compensatory increase in GFR after reduced compared to the 2K WAG [9, 14] . In ACI rats in the present study, hardly any renal damage develops UNx in F 1 rats is larger than the decrease in GFR caused by NO synthase inhibition. even after a substantial elevation of systemic blood pressure. However, normal blood pressure is no guarAlthough our data strongly suggest an important role for the elevated blood pressure in the development antee for low susceptibility. The Milan normotensive rat, in contrast to the Milan hypertensive rat spontan-of glomerular damage, the effects of reducing synthesis may have other effects on the kidney as well. Likewise, eously develops renal damage without the development of hypertension [15] .
chronic ACE-i mediates more than reverse the hypertension. When angiotensin II (Ang II ) formation is Similar to male FHH rats, male Munich-WistarFromter (MWF ) rats spontaneously develop glomer-chronically inhibited with ACEI, glomerular hypertension is controlled while glomerular hyperfiltration is ular and systemic hypertension [16 ] , which is also greatly worsened by UNx [17] . In spontaneously usually unaffected. In contrast, when Ang II activity is increased by chronic infusion, intraglomerular preshypertensive rats (SHR), where systemic blood pressure is much higher, glomerulosclerosis and renal fail-sure, proteinuria, and FGS are further elevated [22] .
Although the role of the renin-angiotensin system ure do not develop early in life [13] . When renal mass is reduced, the resistance of the afferent arteriole (RAS ) in chronic NO inhibition remains somewhat controversial, the development of hypertension in this decreases in SHR and allows the transmission of systemic hypertension into the glomerular capillary model is thought to be renin-dependent and may result partly from increased vascular Ang II receptor expresnetwork [13] . Subsequent proteinuria ( UpV ) develops, albeit much more slowly than in FHH and MWF rats sion [23] . Various reports suggest that the endothelial NO synthase system and the RAS interact as regulators following UNx [10, 11] . Even a further increase in systemic pressure using L-NAME does not severely of the glomerular microcirculation [24] .
Another interesting finding was that, at similar doses impair renal function in SHR because of adequate control of afferent arteriolar resistance [18] . Thus, it of L-NAME, SBP increased significantly more in F 1 define severity of renal damage after L-NAME-induced hyperrats than ACI rats at both 6 and 12 weeks after UNx.
tension. J Am Soc Nephrol 1998; 9: [363] [364] [365] [366] [367] [368] [369] [370] [371] In our previous studies [7] , higher doses of L-NAME 
